- Home
- JBT vs CORT Comparison
JBT vs CORT Comparison
Compare JBT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBT
- CORT
- Stock Information
- Founded
- JBT 1994
- CORT 1998
- Country
- JBT United States
- CORT United States
- Employees
- JBT N/A
- CORT N/A
- Industry
- JBT Industrial Machinery/Components
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- JBT Industrials
- CORT Health Care
- Exchange
- JBT Nasdaq
- CORT Nasdaq
- Market Cap
- JBT 3.0B
- CORT 3.6B
- IPO Year
- JBT N/A
- CORT N/A
- Fundamental
- Price
- JBT $87.82
- CORT $34.38
- Analyst Decision
- JBT Buy
- CORT Strong Buy
- Analyst Count
- JBT 1
- CORT 4
- Target Price
- JBT $121.00
- CORT $56.50
- AVG Volume (30 Days)
- JBT 202.3K
- CORT 532.3K
- Earning Date
- JBT 10-22-2024
- CORT 10-30-2024
- Dividend Yield
- JBT 0.46%
- CORT N/A
- EPS Growth
- JBT 315.83
- CORT 39.48
- EPS
- JBT 17.91
- CORT 1.13
- Revenue
- JBT $1,642,800,000.00
- CORT $569,610,000.00
- Revenue This Year
- JBT $4.72
- CORT $39.14
- Revenue Next Year
- JBT $4.70
- CORT $18.30
- P/E Ratio
- JBT $20.63
- CORT $30.39
- Revenue Growth
- JBT N/A
- CORT 33.04
- 52 Week Low
- JBT $86.12
- CORT $20.84
- 52 Week High
- JBT $111.43
- CORT $39.75
- Technical
- Relative Strength Index (RSI)
- JBT 42.90
- CORT 49.98
- Support Level
- JBT $86.12
- CORT $33.34
- Resistance Level
- JBT $89.65
- CORT $35.58
- Average True Range (ATR)
- JBT 2.34
- CORT 1.15
- MACD
- JBT 0.14
- CORT -0.10
- Stochastic Oscillator
- JBT 29.57
- CORT 40.00
About JBT John Bean Technologies Corporation
John Bean Technologies Corp is a food tech business that provides both customized and turnkey industrial solutions for the food and beverage industry, including a large variety of protein processing and packaging solutions, as well as fruit and juice extraction and ready-to-eat solutions.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.